Package 33342-249-11

Brand: repaglinide

Generic: repaglinide
NDC Package

Package Facts

Identity

Package NDC 33342-249-11
Digits Only 3334224911
Product NDC 33342-249
Description

100 TABLET in 1 BOTTLE (33342-249-11)

Marketing

Marketing Status
Marketed Since 2023-03-22
Brand repaglinide
Generic repaglinide
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "7a93246c-9323-40c4-b590-a40dcb133c8c", "openfda": {"nui": ["N0000175428", "N0000175448"], "upc": ["0333342248114", "0333342249449", "0333342250117", "0333342250445", "0333342249111"], "unii": ["668Z8C33LU"], "rxcui": ["200256", "200257", "200258"], "spl_set_id": ["7a93246c-9323-40c4-b590-a40dcb133c8c"], "pharm_class_epc": ["Glinide [EPC]"], "pharm_class_moa": ["Potassium Channel Antagonists [MoA]"], "manufacturer_name": ["Macleods Pharmaceuticals Limited"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET in 1 BOTTLE (33342-249-11)", "package_ndc": "33342-249-11", "marketing_start_date": "20230322"}, {"sample": false, "description": "1000 TABLET in 1 BOTTLE (33342-249-44)", "package_ndc": "33342-249-44", "marketing_start_date": "20230322"}], "brand_name": "Repaglinide", "product_id": "33342-249_7a93246c-9323-40c4-b590-a40dcb133c8c", "dosage_form": "TABLET", "pharm_class": ["Glinide [EPC]", "Potassium Channel Antagonists [MoA]"], "product_ndc": "33342-249", "generic_name": "Repaglinide", "labeler_name": "Macleods Pharmaceuticals Limited", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Repaglinide", "active_ingredients": [{"name": "REPAGLINIDE", "strength": "1 mg/1"}], "application_number": "ANDA207209", "marketing_category": "ANDA", "marketing_start_date": "20230322", "listing_expiration_date": "20261231"}